Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Shapiro

Showing results (1011-1020 of 1,171) with videos related to

Pageof 118
Sort By:
Nature Medicine|January 15, 2020
Antitumor activity of crizotinib in lung cancers harboring a MET exon 14 alterationAlexander Drilon, Jeffrey W Clark, Jared Weiss, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 5, 2006
Epidermal growth factor receptor variant III mutations in lung tumorigenesis and sensitivity to tyrosine kinase inhibitorsHongbin Ji, Xiaojun Zhao, Yuki Yuza, et al.
Cancer Discovery|June 14, 2025
Phase Ib basket expansion trial and alternative-schedule dose-escalation study of ATR inhibitor elimusertib in advanced solid tumors with DNA damage response defectsTimothy A Yap, David S P Tan, Anastasios Stathis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2020
Clinical Efficacy and Molecular Response Correlates of the WEE1 Inhibitor Adavosertib Combined with Cisplatin in Patients with Metastatic Triple-Negative Breast CancerTanya E Keenan, Tianyu Li, Tuulia Vallius, et al.
JCO Precision Oncology|April 18, 2024
Randomized Phase II Study of Gemcitabine With or Without ATR Inhibitor Berzosertib in Platinum-Resistant Ovarian Cancer: Final Overall Survival and Biomarker AnalysesPanagiotis A Konstantinopoulos, Su-Chun Cheng, Elizabeth K Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2022
Report of the First International Symposium on NUT CarcinomaChristopher A French, Michael L Cheng, Glenn J Hanna, et al.
The Journal of Trauma and Acute Care Surgery|May 11, 2026
Video versus direct laryngoscopy for tracheal intubation in trauma: A secondary analysis of the DEVICE trialStacy A Trent, Steven G Schauer, Matthew E Prekker, et al.
The Journal of Clinical Investigation|February 3, 2026
Plasma chondroitin sulfate predicts the effectiveness of fluid resuscitation strategies in patients with sepsisKaori Oshima, Bailu Yan, Ran Tao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2026
Avutometinib, Abemaciclib, and Fulvestrant in Patients with HR+/HER2- Metastatic Breast Cancer Previously Treated with CDK4/6 Inhibitor: A Single-Arm Phase I TrialAdrienne G Waks, Elia Segui, Tianyu Li, et al.
Diagnostics (Basel, Switzerland)|July 15, 2026
The Sepsis ImmunoScore Predicts Sepsis, Mortality, and Deterioration Better than Clinical Scores and Widely Available BiomarkersGregory L Watson, Lincoln C Updike, Carlos G López-Espina, et al.
Pageof 118

Showing results (1011-1020 of 1,171) with videos related to

Sort By:
Pageof 118
Nature Medicine|January 15, 2020
Antitumor activity of crizotinib in lung cancers harboring a MET exon 14 alterationAlexander Drilon, Jeffrey W Clark, Jared Weiss, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 5, 2006
Epidermal growth factor receptor variant III mutations in lung tumorigenesis and sensitivity to tyrosine kinase inhibitorsHongbin Ji, Xiaojun Zhao, Yuki Yuza, et al.
Cancer Discovery|June 14, 2025
Phase Ib basket expansion trial and alternative-schedule dose-escalation study of ATR inhibitor elimusertib in advanced solid tumors with DNA damage response defectsTimothy A Yap, David S P Tan, Anastasios Stathis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2020
Clinical Efficacy and Molecular Response Correlates of the WEE1 Inhibitor Adavosertib Combined with Cisplatin in Patients with Metastatic Triple-Negative Breast CancerTanya E Keenan, Tianyu Li, Tuulia Vallius, et al.
JCO Precision Oncology|April 18, 2024
Randomized Phase II Study of Gemcitabine With or Without ATR Inhibitor Berzosertib in Platinum-Resistant Ovarian Cancer: Final Overall Survival and Biomarker AnalysesPanagiotis A Konstantinopoulos, Su-Chun Cheng, Elizabeth K Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2022
Report of the First International Symposium on NUT CarcinomaChristopher A French, Michael L Cheng, Glenn J Hanna, et al.
The Journal of Trauma and Acute Care Surgery|May 11, 2026
Video versus direct laryngoscopy for tracheal intubation in trauma: A secondary analysis of the DEVICE trialStacy A Trent, Steven G Schauer, Matthew E Prekker, et al.
The Journal of Clinical Investigation|February 3, 2026
Plasma chondroitin sulfate predicts the effectiveness of fluid resuscitation strategies in patients with sepsisKaori Oshima, Bailu Yan, Ran Tao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2026
Avutometinib, Abemaciclib, and Fulvestrant in Patients with HR+/HER2- Metastatic Breast Cancer Previously Treated with CDK4/6 Inhibitor: A Single-Arm Phase I TrialAdrienne G Waks, Elia Segui, Tianyu Li, et al.
Diagnostics (Basel, Switzerland)|July 15, 2026
The Sepsis ImmunoScore Predicts Sepsis, Mortality, and Deterioration Better than Clinical Scores and Widely Available BiomarkersGregory L Watson, Lincoln C Updike, Carlos G López-Espina, et al.
Pageof 118